Structures by: Britton E.
Total: 6
Tris-(3-chloropyridyl)(methyl(cyclotriguaiacylenyl)methylbenzimidazol-2-ylidene)palladium(II) iodide pentane dichloromethane clathrate
C66H60Cl3I6N9O6Pd3,C5H12,C5H10,0.5(CH2Cl2),2.5(O)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 39 14687-14695
a=15.6946(6)Å b=15.8484(8)Å c=21.6110(10)Å
α=104.839(4)° β=111.072(4)° γ=98.298(3)°
Trans-(3-chloropyridyl)-1-(2-methoxyphenyoxy)methyl-3-methylbenzimidazol-2-ylidene palladium(II) iodide
C21H20ClI2N3O2Pd
Dalton transactions (Cambridge, England : 2003) (2019) 48, 39 14687-14695
a=13.6170(5)Å b=10.99476(3)Å c=15.82037(5)Å
α=90° β=93.4572(3)° γ=90°
2(I),2(C16H17N2O2)
2(I),2(C16H17N2O2)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 39 14687-14695
a=9.81010(10)Å b=11.69940(10)Å c=14.63640(10)Å
α=83.3170(10)° β=83.0190(10)° γ=74.0510(10)°
Tris-methyl(methylbenzimidazol-1-yl)cyclotriguaiacylenyl hexafluorophosphate
3(F6P),C51H51N6O6
Dalton transactions (Cambridge, England : 2003) (2019) 48, 39 14687-14695
a=7.4847(9)Å b=16.4088(17)Å c=22.788(3)Å
α=75.410(11)° β=80.946(12)° γ=78.773(10)°
Tris-(3-chloropyridyl)(methyl(cyclotriguaiacylenyl)methylbenzimidazol-2-ylidene)palladium(II) iodide dioxane clathrate
2(C66H59Cl3I6N9O6Pd3),5.5(C4H8O2)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 39 14687-14695
a=18.4409(5)Å b=21.9443(8)Å c=23.7505(8)Å
α=99.360(3)° β=97.234(3)° γ=103.156(3)°
Trans-(3-chloropyridyl)-1-(2-methoxyphenyoxy)methyl-3-benzyllbenzimidazol-2-ylidene palladium(II) iodide
2(C27H24ClI2N3O2Pd)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 39 14687-14695
a=11.02430(10)Å b=14.5623(2)Å c=35.8034(5)Å
α=90° β=98.4410(10)° γ=90°